Tesla’s Weakest Quarter in Years: Deliveries Miss Expectations
Tesla’s Q1 sales fell short, EV demand slows, older models lag, but investors watch robotaxis and AI plans.
Already have an account? Sign in.
Tesla’s Q1 sales fell short, EV demand slows, older models lag, but investors watch robotaxis and AI plans.
Supermicro announced a $7 billion equity and equity-linked offering to fund $39 billion in new AI server orders from over 20 customers.
Cellectis got FDA RMAT for lasme-cel, an off-the-shelf CAR-T therapy for hard-to-treat leukemia that may speed up patient access.
Cracker Barrel beat expectations, raised outlook, and saw shares jump as turnaround efforts and strong execution boost confidence.